{
    "code": 0,
    "data": [
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of earnings conference call Q3 FY25-26",
            "news_id": "54c040da-6b61-4435-8049-a0df072e8d26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec2824b7-a917-4b22-a59a-66dfc9532dd8.pdf",
            "news_date": "2026-02-12 18:07:55",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q3 earning  for FY 2025-26",
            "news_id": "df996c37-b072-4210-be86-8306658d4c08",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=236bc8c2-778b-4af2-a104-b4e902651e29.pdf",
            "news_date": "2026-02-12 15:04:56",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un Audited Financial Results For The Quarter Ending 31St December 2025",
            "news_body": "Un audited Financial Results for the quarter ending 31st December 2025",
            "news_id": "7da53498-9d53-4372-9921-2373d20a2392",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4f3defc-e429-4997-ab79-1a096fb5d689.pdf",
            "news_date": "2026-02-12 14:49:23",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for the quarter and half year ended September 30 2025 held on November 14 2025",
            "news_id": "a1e4e501-6c2c-4aaf-8440-3d7c4bc73b60",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac8f848f-8703-4403-9ae3-cb2d420d47da.pdf",
            "news_date": "2025-11-20 16:39:44",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the Financial Results for the quarter and half year ended 30th September 2025",
            "news_id": "31221785-ea0e-495d-9078-174f8daee992",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5fe60cd-6aa5-4ff4-9fd3-1e93a3014e6e.pdf",
            "news_date": "2025-11-14 15:07:43",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Outcome of the Board Meeting",
            "news_id": "ffb45051-a929-448a-90ae-0ec960958725",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a28a0f3b-934c-4399-ab82-f394a1e15065.pdf",
            "news_date": "2025-11-14 13:44:12",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Call Presentation for the quarter ended 30th June 2025",
            "news_id": "954eb01a-a17f-44d5-8cc7-162e0790ae47",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c755548f-c325-46ba-8d7a-8c2108a36a18.pdf",
            "news_date": "2025-08-12 17:38:13",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Financial Results for the quarter ended 30th June 2025",
            "news_id": "c358a702-89fd-4f83-b239-282996778fcd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f60029ee-facd-467a-be0e-d7087b619896.pdf",
            "news_date": "2025-08-12 13:42:42",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Investor Call held on 23rd July 2025",
            "news_id": "362956f4-9254-4063-8729-24e910791709",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26c8d332-fc11-4299-9977-cb8dc43d0153.pdf",
            "news_date": "2025-07-29 16:40:29",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Proposed Investment.",
            "news_id": "a9409a6b-022c-439e-9975-3b9265b7aefd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c9d7cd0-d102-42c5-89b3-f91787622f9d.pdf",
            "news_date": "2025-07-23 16:36:43",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY24-25 Earnings call transcript",
            "news_id": "29117c0c-ae17-4bd6-93ee-09c16149e955",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d43e2593-6819-4d99-b9a6-c3019c901490.pdf",
            "news_date": "2025-06-04 16:28:04",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and year ended 31st March 2025",
            "news_id": "12e1b7d0-a251-4a91-af50-bd1ff1b30355",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aea686c3-f820-4f09-a6a6-99e3468a4042.pdf",
            "news_date": "2025-05-28 18:24:58",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3 FY25 Earning Call Transcript",
            "news_id": "2a29dd85-b188-4cd3-85a5-17fba8263bb1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=649d3521-2c1e-4ecd-ab9c-0b1292bb5559.pdf",
            "news_date": "2025-02-19 15:41:06",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 FY25 Earnings Presentation",
            "news_id": "b796dd13-21c6-490b-92bd-89b734b5815e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7aee70f-0287-4ff8-8d04-253ad95cd48e.pdf",
            "news_date": "2025-02-12 17:08:49",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended December 31 2024",
            "news_id": "9921eb7d-9526-459b-9ddd-bd7190c3e078",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78c06fa9-fa0e-4350-8f28-6643f3a445b3.pdf",
            "news_date": "2025-02-12 16:03:21",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of earnings conference call Q2 FY25",
            "news_id": "f6e240e5-8237-4f74-a835-09e88383fc7e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=228fbdd9-f03b-4420-b177-3290c1f4e784.pdf",
            "news_date": "2024-11-13 16:49:27",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and half year ended 30th September, 2024",
            "news_id": "2f476457-f8f3-46bf-b24c-eda15bf9ac35",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=823a6560-df98-4753-b710-06bf7709d994.pdf",
            "news_date": "2024-11-12 17:15:55",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2024",
            "news_body": "Unaudited Financial Results for the quarter and half year ended 30th September, 2024",
            "news_id": "3c93d076-c350-4067-bb79-412d77feaafe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f43a9833-9804-4ef8-8e4d-fe9fa4ae381f.pdf",
            "news_date": "2024-11-12 14:30:05",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "4ed8946f-92c3-4eaf-94a5-7d9e3716ea6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dba08330-79f4-449b-bfa2-8f5fde18a088.pdf",
            "news_date": "2024-08-21 11:45:37",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Audio Recording weblink",
            "news_id": "2e7c5b66-fcc9-4f34-ab08-df7477207ff0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22635544-7f5f-4c0f-86cf-264c562cf1d7.pdf",
            "news_date": "2024-08-13 17:11:59",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter ended 30th June, 2024",
            "news_id": "bbc04c5b-677f-4121-b7e5-082cb4a659cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4dc8fe95-cdce-4e13-8265-43179359b5cb.pdf",
            "news_date": "2024-08-12 18:38:28",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2024",
            "news_body": "Unaudited Financial Results for the quarter ended 30th June, 2024 along with Limited Review Report",
            "news_id": "2e4f89bc-14b5-4ab3-812c-2c6ff6642369",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed474fc3-2de9-4482-a9fb-7ccec5a48183.pdf",
            "news_date": "2024-08-12 14:00:50",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript for the Earnings call held on 28th May, 2024",
            "news_id": "302a8467-11e6-45ad-9603-da8bb3b73be4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99cc0f91-9fd5-4d78-b404-a4e50d143d60.pdf",
            "news_date": "2024-06-04 13:06:00",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "8d0488eb-e159-4af0-bbd6-1c3aafe20828",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75d97ed4-da5e-4d74-ac80-7744c13a2f59.pdf",
            "news_date": "2024-05-29 19:11:30",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Earnings call Audio Recording",
            "news_id": "64d0dbe4-4d28-46ed-9531-cd99553e5073",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c34d483-d5ab-48aa-b134-bfd6db34e28d.pdf",
            "news_date": "2024-05-29 11:46:16",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation on the Audited Financial Results for the quarter and year ended 31st Match, 2024",
            "news_id": "74d7c9ea-4d1e-45f8-95fb-166765096d26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92ba56ca-3913-4cf9-8a4e-8ced6baa567d.pdf",
            "news_date": "2024-05-28 10:33:40",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March, 2024",
            "news_body": "Audited Financial Results for the quarter and year ended 31st March, 2024",
            "news_id": "4e5518d4-5135-4311-9f18-d7d809112781",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d20e5ade-c5bb-4e20-ad83-4110f4b838d4.pdf",
            "news_date": "2024-05-27 16:42:36",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Concall Transcript for the quarter and nine months ended December 31, 2023",
            "news_id": "037602c0-fc11-4c7a-af93-b31e705f041a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98ef9451-83a8-4657-acce-18d31611b872.pdf",
            "news_date": "2024-02-21 16:58:48",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of earnings conference call Q3 FY24",
            "news_id": "c6b0f431-4ff9-4093-a3c1-6cd812da53b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b128937d-9201-4baa-a3a6-3e8c615bd2ab.pdf",
            "news_date": "2024-02-15 16:48:49",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and nine months ended December 31, 2023",
            "news_id": "ae8c25dc-c0db-4afc-915f-c0b202919b29",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66e85b23-3234-404f-986a-92887b4c90dd.pdf",
            "news_date": "2024-02-15 10:16:20",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2023",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended 31st December, 2023",
            "news_id": "c42b0c11-e469-447d-83a8-9d47eb732803",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4c87be9-9d52-4418-8487-470cbb155c89.pdf",
            "news_date": "2024-02-14 14:08:48",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of earnings conference call Q2 FY24",
            "news_id": "bb15938d-f9aa-4695-9075-c5b7c926dfc1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=680ba284-253e-4453-bc47-037b6d722b8a.pdf",
            "news_date": "2023-11-16 11:37:25",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q2FY24 Results",
            "news_id": "885b375e-20b6-4865-87f3-b7050f6a9e74",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d6d07ff-6eea-4bf3-8b21-89d9b1f3211f.pdf",
            "news_date": "2023-11-15 13:57:03",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended 30Th September, 2023",
            "news_body": "Financial Results for the quarter and half year ended 30th September, 2023",
            "news_id": "2e2a95ac-f9bd-4c46-859f-34e22ec552a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba38ed7d-3f18-422a-9967-8c55f14008a3.pdf",
            "news_date": "2023-11-14 14:14:47",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call transcript for the quarter ended June 30, 2023",
            "news_id": "6d6f2e26-cacb-4156-b859-835d62d3fa4d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8bcbab47-7dc2-43c5-bf21-1a30b450a20c.pdf",
            "news_date": "2023-08-14 14:11:15",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Quarter ended 30th June 2023",
            "news_id": "45a654a5-e26b-4d49-ada0-e62697cff46a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4f2169d-4a45-478e-a28e-fc799b8fc73f.pdf",
            "news_date": "2023-08-10 15:00:51",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of Concall Q1FY2024",
            "news_id": "ff54cc9e-2866-491e-a797-5ccb977a601c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7546b2b7-f17e-4ef9-9640-4dc836120f60.pdf",
            "news_date": "2023-08-10 13:04:42",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2023",
            "news_body": "Unaudited Financial Results for the quarter ended 30th June, 2023<BR>",
            "news_id": "378b9d54-586b-4fc8-8c20-4e011c9075a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b83d87c9-b715-4aa0-9aa5-9874b5afe281.pdf",
            "news_date": "2023-08-09 14:50:08",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY23 Earnings Call Transcript",
            "news_id": "d9c8aaea-9a68-457b-87f2-e492ce5ffd4e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c09fc44f-6b60-46c9-b248-1d3f3e0244a1.pdf",
            "news_date": "2023-06-01 12:56:21",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and year ended 31st March, 2023",
            "news_id": "2251a9c5-e031-4a65-89bb-ed779226b938",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=495f5c02-ec86-4da0-87c7-8aa114cac34a.pdf",
            "news_date": "2023-05-30 15:10:20",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Audio recording link",
            "news_id": "c90035bf-805a-4168-9129-0aa0b60a4934",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17fcbdab-740e-40c8-997e-2b4752b6e353.pdf",
            "news_date": "2023-05-30 13:51:07",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31St March, 2023",
            "news_body": "Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2023",
            "news_id": "c6ba50ca-0cb5-4958-8ec7-73c51d934c13",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e80bc817-d9b8-44f8-bf70-660996b14349.pdf",
            "news_date": "2023-05-29 14:22:16",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company''s earnings conference call for Q3 FY23 held on 10th February, 2023",
            "news_id": "3a7a9b1b-5db6-4468-b700-79f0fb18be52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e4b6eb8-33de-4abd-82c2-b060768c6750.pdf",
            "news_date": "2023-02-13 11:48:01",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio Transcript of the Earnings call for the Q3 FY23",
            "news_id": "95cafb29-e74b-4c34-9d62-6f8644f6513e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=511a9a76-a53f-41f2-8da4-37ad7af5b7a6.pdf",
            "news_date": "2023-02-10 16:23:40",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and nine months ended 31st December, 2022",
            "news_id": "bbd7f3f3-8abe-4567-949f-bbb1e004ed5a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d4c5821-288a-4585-bdd0-08579289e005.pdf",
            "news_date": "2023-02-09 17:40:41",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Outcome of the Board Meeting for the un audited financial results for the quarter ended 31st December, 2022",
            "news_id": "8f545982-dc27-4c31-91d1-f5f8d0e42087",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c257f87-a51e-49b3-83cb-6039dda94271.pdf",
            "news_date": "2023-02-09 14:00:46",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Half Year Ended 30Th September, 2022",
            "news_body": "Related Party Transactions for the half year ended 30th September, 2022",
            "news_id": "693097f9-7824-4b8e-afaa-48a753f092a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e3df443-5edb-4c91-a080-90b4b23ec76e.pdf",
            "news_date": "2022-11-22 16:26:54",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 FY2023 Earnings call Audio Transcript",
            "news_id": "29c0319f-dbb3-4842-8b50-265c68328f98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9274967b-6fbd-4387-a188-459d24a71eb9.pdf",
            "news_date": "2022-11-11 15:22:30",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Q2 2023 Financial Results",
            "news_id": "56b8ddb3-46ce-41a7-b004-ae9a7490ad56",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16dfcdc8-3180-4ff0-931a-d35316b2cb52.pdf",
            "news_date": "2022-11-11 12:52:24",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Outcome of the Board Meeting held on 10-Nov-2022 to consider the unaudited financial Results for the quarter and half year ended 30th September 2022 and  declared 2nd Interim Dividend of Rs.0.75 (i.e., 37.50%) per Equity shares of Rs.2/- each",
            "news_id": "7be40297-d7b2-4d21-8e6d-75987a39060f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=093fdc5a-f8da-48f4-9148-49696b7ad15b.pdf",
            "news_date": "2022-11-10 13:41:22",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the Q1 FY22-23",
            "news_id": "93f853f6-1a54-4846-8d8f-cd36a4931ae4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25b58ba7-48ac-4df7-9b6e-c83ac4a01c76.pdf",
            "news_date": "2022-08-17 17:17:20",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "weblink for the Audio Transcript for the  Earnings call  held on 10th August, 2022",
            "news_id": "f4b09abc-ba8b-49b7-8a23-46703136d6b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b38c135c-32ae-42bb-bc9f-67b740d71d31.pdf",
            "news_date": "2022-08-10 15:56:29",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter ended 30th June, 2022",
            "news_id": "4c018fd7-60e3-42da-9de1-c956c4119a32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68e8f38a-f648-4caf-9a87-5ca041068fc7.pdf",
            "news_date": "2022-08-10 13:18:26",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2022 And Interim Dividend",
            "news_body": "Unaudited Financial Results for the Quarter ended 30th June, 2022 and Interim Dividend of Rs.3.50 per equity share of Rs.2/- each",
            "news_id": "2252e38d-53da-4a95-b706-1f30c498a2f5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c41b5d9b-0606-4ddf-8fe9-f034b84bdb95.pdf",
            "news_date": "2022-08-09 14:01:23",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended 30Th June, 2022 And Interim Dividend",
            "news_body": "Unaudited Financial Results for the Quarter ended 30th June, 2022 and Interim Dividend of Rs.3.50 per equity share of Rs.2/- each",
            "news_id": "35675cc9-a529-409b-aad5-dcaa0455981e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99d5faca-8426-483e-99d8-39c642494faf.pdf",
            "news_date": "2022-08-09 13:58:15",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 31 March, 2022",
            "news_body": "Disclosure of Related Party Transactions for the half year ended 31 March, 2022",
            "news_id": "b6ec6e48-b56d-4ada-88a2-98948257c091",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c570a312-d2d2-4f00-83d4-18d8de21b193.pdf",
            "news_date": "2022-06-13 16:18:02",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q4 FY22 Investor Presentation",
            "news_id": "9a4552cb-71d9-48c5-85fb-ae5e6d1f5753",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ada7c08-5682-4e78-8a85-d6d499d79736.pdf",
            "news_date": "2022-06-07 12:23:45",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY 2022 Earnings Call Transcript",
            "news_id": "19a48687-5f64-4480-95ef-4904ce413208",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59238945-3195-4715-8cff-15f626b21d25.pdf",
            "news_date": "2022-06-04 09:38:19",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Recording of Analysts/Institutional Investor Meet/Con. Call held on 31st May, 2022",
            "news_id": "454d25f0-4c90-4a9e-8ef3-fc0bdc8d8899",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e14d5b2-6ab8-40d3-9436-393d6532f034.pdf",
            "news_date": "2022-05-31 16:25:38",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended 31St March, 2022",
            "news_body": "Financial Results for the quarter and year ended 31st March, 2022",
            "news_id": "42231af8-2d04-435c-afb1-690c22e1bab3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97a260bf-b5c4-4c67-81cb-2a99176c5e64.pdf",
            "news_date": "2022-05-30 14:54:29",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and nine months ended 31st December 2021",
            "news_id": "c96ac20b-f298-45fe-b78b-4a8765062667",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7172470b-6a41-49e6-960c-8d7a9de0b5b8.pdf",
            "news_date": "2022-02-17 17:17:20",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Un audited Financial Results for the Quarter ended 31st December, 2021",
            "news_id": "f2db69b1-0dd3-487f-9ee0-d4e71202935e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=582179e6-49ed-4dd3-a963-843d71d1bbc0.pdf",
            "news_date": "2022-02-14 16:46:11",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter ended September 30, 2021",
            "news_id": "ea7dfccf-45a5-482a-8b4f-692e3f5d7c2d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8dcbceb7-b74f-4ac5-91b3-451a0189a6e8.pdf",
            "news_date": "2021-11-15 11:37:51",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome",
            "news_body": "Unaudited Financial Results for the quarter and half year ended 30th September, 2021<BR>",
            "news_id": "d12a4a3a-b25e-4cc6-b18c-6c03947e0a7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac96a9b1-c988-4c34-88f7-0fa7bd8f17de.pdf",
            "news_date": "2021-11-11 14:28:36",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter ended June 30, 2021",
            "news_id": "e56a1e8a-ea59-453e-900b-0a74aafae61a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de0dc8f6-b8ac-4b4c-abff-be5bb4e4b5b0.pdf",
            "news_date": "2021-08-18 12:33:38",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un Audited Financial Results For The Quarter Ended June 30, 2021 Under Regulation 33 Of SEBI (LODR) Regulations, 2015",
            "news_body": "Un Audited Financial Results for the quarter ended June 30, 2021 under Regulation 33 of SEBI (LODR) Regulations, 2015",
            "news_id": "9953c3da-2331-4411-a434-6d2ba0db753d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22c32dca-0c5d-451f-bf66-8e6344b1fb88.pdf",
            "news_date": "2021-08-12 13:23:00",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transaction For The FY 2020-21",
            "news_body": "Related Party Transaction for the FY 2020-21",
            "news_id": "da8e9b97-44e4-4c04-85a0-a5aa63e5bf5d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ba44c83-a970-42c6-8c9e-f64ecda9d154.pdf",
            "news_date": "2021-07-12 12:34:18",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q4 Investor presentation for the FY 2020-21",
            "news_id": "3a1931c5-6351-4168-b5fc-a43a7d46f54d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11064eb4-92a6-4f58-a3ac-2e16a8531a2a.pdf",
            "news_date": "2021-07-12 12:26:59",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For FY 20-21",
            "news_body": "Audited Financial Results for  FY 20-21",
            "news_id": "d88b1e77-1fd5-41f3-9623-58e40fe6f88a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6462e782-c983-4cc0-94bc-9a490f91d990.pdf",
            "news_date": "2021-06-17 15:40:35",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCOPHARM",
            "disp": "Natco Pharma",
            "bse_code": 524816,
            "isin": "INE987B01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for the quarter and nine months ended December 31, 2020",
            "news_id": "fb68626a-a192-41a0-85fd-7a39aa273d5f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8501c6ab-9f8e-4565-8384-fb0126f709a7.pdf",
            "news_date": "2021-02-15 15:25:35",
            "seo": "natco-pharma-ltd",
            "ltp": 850.8,
            "ch": 3.849999999999909,
            "pch": 0.454572288800981,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3918,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}